{"id":"https://openalex.org/W2035274147","doi":"https://doi.org/10.3810/pgm.2013.05.2659","title":"Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes","display_name":"Cardiovascular Effects of Dipeptidyl Peptidase-4 Inhibitors: From Risk Factors to Clinical Outcomes","alternate_titles":[],"publication_year":2013,"publication_date":"2013-05-01","ids":{"openalex":"https://openalex.org/W2035274147","doi":"https://doi.org/10.3810/pgm.2013.05.2659","mag":"2035274147","pmid":"https://pubmed.ncbi.nlm.nih.gov/23748503"},"language":"en","primary_location":{"id":"doi:10.3810/pgm.2013.05.2659","doi":"https://doi.org/10.3810/pgm.2013.05.2659","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2013.05.2659","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2035274147"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://orbi.uliege.be/bitstream/2268/152153/1/pgm%20Cv%20effects%20of%20ddp4%20inhibitors.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039563874","display_name":"Andr\u00e9 Jacques Scheen","orcid":"https://orcid.org/0000-0001-9743-4371","observed_orcids":["https://orcid.org/0000-0001-9743-4371"]},"institutions":[{"id":"https://openalex.org/I157674565","display_name":"University of Li\u00e8ge","ror":"https://ror.org/00afp2z80","country_code":"BE","type":"education","lineage":["https://openalex.org/I157674565"]},{"id":"https://openalex.org/I4210134544","display_name":"Centre Hospitalier Universitaire de Li\u00e8ge","ror":"https://ror.org/044s61914","country_code":"BE","type":"healthcare","lineage":["https://openalex.org/I4210134544"]}],"countries":["BE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Andr\u00e9 J. Scheen","raw_affiliation_strings":["Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, University of Li\u00e8ge, Li\u00e8ge, Belgium. andre.scheen@chu.ulg.ac.be","Division of Clinical Pharmacology, Department of Medicine, CHU Sart Tilman, University of Li\u00e8ge, Li\u00e8ge, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Diabetes, Nutrition and Metabolic Disorders, Department of Medicine, CHU Sart Tilman, University of Li\u00e8ge, Li\u00e8ge, Belgium. andre.scheen@chu.ulg.ac.be","institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"]},{"raw_affiliation_string":"Division of Clinical Pharmacology, Department of Medicine, CHU Sart Tilman, University of Li\u00e8ge, Li\u00e8ge, Belgium","institution_ids":["https://openalex.org/I157674565"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5039563874"],"corresponding_institution_ids":["https://openalex.org/I157674565","https://openalex.org/I4210134544"],"apc_list":null,"apc_paid":null,"fwci":1.8336,"has_fulltext":true,"cited_by_count":90,"citation_normalized_percentile":{"value":0.8615153,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":100},"biblio":{"volume":"125","issue":"3","first_page":"7","last_page":"20"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.9079999923706055},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9330000281333923},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.7870000004768372},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.9340000152587891},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.7820000052452087},{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.8820000290870667},{"id":"https://openalex.org/keywords/sitagliptin","display_name":"sitagliptin","score":0.9150000214576721},{"id":"https://openalex.org/keywords/saxagliptin","display_name":"saxagliptin","score":0.9769999980926514},{"id":"https://openalex.org/keywords/alogliptin","display_name":"alogliptin","score":0.9120000004768372},{"id":"https://openalex.org/keywords/linagliptin","display_name":"linagliptin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/vildagliptin","display_name":"vildagliptin","score":0.9120000004768372},{"id":"https://openalex.org/keywords/endothelial-function","display_name":"endothelial function","score":0.6740000247955322},{"id":"https://openalex.org/keywords/postprandial-lipemia","display_name":"postprandial lipemia","score":0.7350000143051147},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.5849999785423279},{"id":"https://openalex.org/keywords/savor-timi-53","display_name":"SAVOR-TIMI 53","score":0.9860000014305115},{"id":"https://openalex.org/keywords/carolina","display_name":"Carolina","score":1.0}],"concepts":[{"id":"https://openalex.org/C2780282729","wikidata":"https://www.wikidata.org/wiki/Q3121121","display_name":"Saxagliptin","level":5,"score":0.9649317264556885},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9489654302597046},{"id":"https://openalex.org/C2779284873","wikidata":"https://www.wikidata.org/wiki/Q419832","display_name":"Sitagliptin","level":4,"score":0.9391880035400391},{"id":"https://openalex.org/C2780012697","wikidata":"https://www.wikidata.org/wiki/Q4734170","display_name":"Alogliptin","level":5,"score":0.8883141279220581},{"id":"https://openalex.org/C2780031085","wikidata":"https://www.wikidata.org/wiki/Q909745","display_name":"Linagliptin","level":4,"score":0.7477505207061768},{"id":"https://openalex.org/C2776453732","wikidata":"https://www.wikidata.org/wiki/Q421042","display_name":"Vildagliptin","level":4,"score":0.7343335151672363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5695540904998779},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5504565834999084},{"id":"https://openalex.org/C156490143","wikidata":"https://www.wikidata.org/wiki/Q412214","display_name":"Dipeptidyl peptidase-4","level":4,"score":0.5237210392951965},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.5219054818153381},{"id":"https://openalex.org/C2778881409","wikidata":"https://www.wikidata.org/wiki/Q1420402","display_name":"Incretin","level":4,"score":0.4990100860595703},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.42051267623901367},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.38216912746429443},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3607894480228424},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.360124409198761}],"mesh":[{"descriptor_ui":"D000068900","descriptor_name":"Sitagliptin Phosphate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077597","descriptor_name":"Vildagliptin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000218","descriptor_name":"Adamantane","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001835","descriptor_name":"Body Weight","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002319","descriptor_name":"Cardiovascular System","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003324","descriptor_name":"Coronary Artery Disease","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D009570","descriptor_name":"Nitriles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011719","descriptor_name":"Pyrazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011759","descriptor_name":"Pyrrolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D014230","descriptor_name":"Triazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D054873","descriptor_name":"Dipeptidyl-Peptidase IV Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3810/pgm.2013.05.2659","doi":"https://doi.org/10.3810/pgm.2013.05.2659","is_oa":false,"landing_page_url":"https://doi.org/10.3810/pgm.2013.05.2659","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},{"id":"pmid:23748503","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23748503","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate medicine","raw_type":"Journal Article"},{"id":"pmh:oai:orbi.ulg.ac.be:2268/152153","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/152153","pdf_url":"https://orbi.uliege.be/bitstream/2268/152153/1/pgm%20Cv%20effects%20of%20ddp4%20inhibitors.pdf","source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Postgraduate Medicine, 125 (3), 7-20 (2013)","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"pmh:oai:orbi.ulg.ac.be:2268/152153","doi":null,"is_oa":true,"landing_page_url":"https://orbi.uliege.be/handle/2268/152153","pdf_url":"https://orbi.uliege.be/bitstream/2268/152153/1/pgm%20Cv%20effects%20of%20ddp4%20inhibitors.pdf","source":{"id":"https://openalex.org/S4306401300","display_name":"ORBi (University of Li\u00e8ge)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I157674565","host_organization_name":"University of Li\u00e8ge","host_organization_lineage":["https://openalex.org/I157674565"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Postgraduate Medicine, 125 (3), 7-20 (2013)","raw_type":"http://purl.org/coar/resource_type/c_6501"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2035274147.pdf","grobid_xml":"https://content.openalex.org/works/W2035274147.grobid-xml"},"referenced_works_count":126,"referenced_works":["https://openalex.org/W20782350","https://openalex.org/W130204912","https://openalex.org/W1557233532","https://openalex.org/W1916480346","https://openalex.org/W1963858032","https://openalex.org/W1964255176","https://openalex.org/W1966189438","https://openalex.org/W1967096313","https://openalex.org/W1968328731","https://openalex.org/W1968925787","https://openalex.org/W1969564926","https://openalex.org/W1971954476","https://openalex.org/W1972258960","https://openalex.org/W1972632636","https://openalex.org/W1975777549","https://openalex.org/W1980018066","https://openalex.org/W1982657942","https://openalex.org/W1983084864","https://openalex.org/W1985164695","https://openalex.org/W1986650917","https://openalex.org/W1987621836","https://openalex.org/W1992519606","https://openalex.org/W1993070711","https://openalex.org/W1996100544","https://openalex.org/W2000113674","https://openalex.org/W2003221950","https://openalex.org/W2004835736","https://openalex.org/W2006853439","https://openalex.org/W2010122800","https://openalex.org/W2016298811","https://openalex.org/W2016951112","https://openalex.org/W2019465801","https://openalex.org/W2019470196","https://openalex.org/W2020292843","https://openalex.org/W2026259786","https://openalex.org/W2027132230","https://openalex.org/W2028317115","https://openalex.org/W2029071587","https://openalex.org/W2030744913","https://openalex.org/W2031723890","https://openalex.org/W2033316662","https://openalex.org/W2033493723","https://openalex.org/W2034171544","https://openalex.org/W2034728834","https://openalex.org/W2036471275","https://openalex.org/W2036526782","https://openalex.org/W2037429235","https://openalex.org/W2041342486","https://openalex.org/W2042503458","https://openalex.org/W2042661216","https://openalex.org/W2042702624","https://openalex.org/W2043804599","https://openalex.org/W2043807347","https://openalex.org/W2044238158","https://openalex.org/W2048544387","https://openalex.org/W2051279660","https://openalex.org/W2052771129","https://openalex.org/W2054354753","https://openalex.org/W2057768222","https://openalex.org/W2058468402","https://openalex.org/W2063040422","https://openalex.org/W2064978103","https://openalex.org/W2067736115","https://openalex.org/W2068291692","https://openalex.org/W2069614922","https://openalex.org/W2071090755","https://openalex.org/W2072239150","https://openalex.org/W2075746385","https://openalex.org/W2082960515","https://openalex.org/W2089095955","https://openalex.org/W2092583867","https://openalex.org/W2095682936","https://openalex.org/W2098289172","https://openalex.org/W2099903872","https://openalex.org/W2100862440","https://openalex.org/W2104079863","https://openalex.org/W2105343220","https://openalex.org/W2106648285","https://openalex.org/W2108292236","https://openalex.org/W2111876001","https://openalex.org/W2113565490","https://openalex.org/W2114481251","https://openalex.org/W2114531479","https://openalex.org/W2114927834","https://openalex.org/W2116254891","https://openalex.org/W2120622647","https://openalex.org/W2124515086","https://openalex.org/W2125653714","https://openalex.org/W2126328471","https://openalex.org/W2126919962","https://openalex.org/W2127472727","https://openalex.org/W2128243640","https://openalex.org/W2129730863","https://openalex.org/W2131343538","https://openalex.org/W2133034433","https://openalex.org/W2134361196","https://openalex.org/W2138256073","https://openalex.org/W2140986962","https://openalex.org/W2142746038","https://openalex.org/W2146466098","https://openalex.org/W2147187810","https://openalex.org/W2147764623","https://openalex.org/W2150359377","https://openalex.org/W2150481523","https://openalex.org/W2150849997","https://openalex.org/W2150859826","https://openalex.org/W2152978153","https://openalex.org/W2156888511","https://openalex.org/W2156900346","https://openalex.org/W2157665742","https://openalex.org/W2158498099","https://openalex.org/W2158506982","https://openalex.org/W2159205789","https://openalex.org/W2159630267","https://openalex.org/W2160286139","https://openalex.org/W2160327592","https://openalex.org/W2166494634","https://openalex.org/W2166538701","https://openalex.org/W2167651200","https://openalex.org/W2167788046","https://openalex.org/W2168626372","https://openalex.org/W2172193326","https://openalex.org/W2188846692","https://openalex.org/W2331319476","https://openalex.org/W2781184586","https://openalex.org/W4235139409"],"related_works":["https://openalex.org/W2016298811","https://openalex.org/W2104580373","https://openalex.org/W1547911633","https://openalex.org/W2124633867","https://openalex.org/W2055715908","https://openalex.org/W2050781927","https://openalex.org/W2497840048","https://openalex.org/W2802176804","https://openalex.org/W4289076153","https://openalex.org/W3150872792"],"abstract_inverted_index":{"Dipeptidyl":[0],"peptidase-4":[1],"(DPP-4)":[2],"inhibitors":[3,58,188],"(gliptins)":[4],"are":[5,77,193],"oral":[6],"incretin-based":[7],"glucose-lowering":[8,164],"agents":[9],"with":[10,106,120,139,151,159,189,198],"proven":[11],"efficacy":[12],"and":[13,28,41,48,76,100,173,200,245,253],"safety":[14],"in":[15,104,118,196,220,225,239,262],"the":[16,42,71,113,167,205,213,233,254,281,295,298],"management":[17,296],"of":[18,55,73,125,129,147,216,237,258,284,297],"type":[19],"2":[20,243,266],"diabetes":[21],"mellitus":[22],"(T2DM).":[23],"In":[24,108],"addition,":[25,109],"preclinical":[26],"data":[27],"mechanistic":[29],"studies":[30],"suggest":[31,134],"a":[32,53,135,140,201,276],"possible":[33,136],"additional":[34],"non-glycemic":[35],"beneficial":[36],"action":[37],"on":[38,112,211,231,251,269],"blood":[39,82],"vessels":[40],"heart,":[43],"via":[44],"both":[45],"glucagon-like":[46,49],"peptide-1-dependent":[47],"peptide-1-independent":[50],"effects.":[51],"As":[52],"matter":[54],"fact,":[56],"DPP-4":[57,171,187,277],"improve":[59,65,85,97],"several":[60],"cardiovascular":[61,149,175,191,203,282],"risk":[62,72],"factors:":[63],"they":[64],"glucose":[66],"control":[67],"(mainly":[68],"by":[69],"reducing":[70],"postprandial":[74,86],"hyperglycemia)":[75],"weight":[78],"neutral;":[79],"may":[80],"lower":[81,145],"pressure":[83],"somewhat;":[84],"(and":[87],"even":[88],"fasting)":[89],"lipemia;":[90],"reduce":[91,101,280],"inflammatory":[92],"markers;":[93],"diminish":[94],"oxidative":[95],"stress;":[96],"endothelial":[98],"function;":[99],"platelet":[102],"aggregation":[103],"patients":[105,119,197],"T2DM.":[107],"positive":[110],"effects":[111],"myocardium":[114],"have":[115],"been":[116],"described":[117],"ischemic":[121],"heart":[122],"disease.":[123,299],"Results":[124],"post":[126],"hoc":[127],"analyses":[128],"phase":[130],"2/3":[131],"controlled":[132],"trials":[133,184,273],"cardioprotective":[137],"effect":[138],"trend":[141],"(sometimes":[142],"significant)":[143],"toward":[144],"incidence":[146],"major":[148,289],"events":[150],"sitagliptin,":[152,212],"vildagliptin,":[153],"saxagliptin,":[154,232],"linagliptin,":[155],"or":[156,161],"alogliptin":[157],"compared":[158],"placebo":[160],"other":[162],"active":[163],"agents.":[165],"However,":[166],"definite":[168],"relationship":[169],"between":[170],"inhibition":[172],"better":[174],"outcomes":[176,192],"remains":[177],"to":[178],"be":[179,288],"proven.":[180],"Major":[181],"prospective":[182],"clinical":[183],"involving":[185],"various":[186],"predefined":[190],"under":[194],"way":[195],"T2DM":[199],"high-risk":[202],"profile:":[204],"Sitagliptin":[206],"Cardiovascular":[207,234,255],"Outcome":[208,256],"Study":[209,236,257],"(TECOS)":[210],"Saxagliptin":[214],"Assessment":[215],"Vascular":[217],"Outcomes":[218,235],"Recorded":[219],"Patients":[221,263],"With":[222,241,264],"Diabetes":[223,244,267],"Mellitus-Thrombolysis":[224],"Myocardial":[226],"Infarction":[227],"(SAVOR-TIMI)":[228],"53":[229],"trial":[230,250],"Alogliptin":[238],"Subjects":[240],"Type":[242,265],"Acute":[246],"Coronary":[247],"Syndrome":[248],"(EXAMINE)":[249],"alogliptin,":[252],"Linagliptin":[259],"Versus":[260],"Glimepiride":[261],"(CAROLINA)":[268],"linagliptin.":[270],"If":[271],"these":[272],"confirm":[274],"that":[275,291],"inhibitor":[278],"can":[279],"burden":[283],"T2DM,":[285],"it":[286],"would":[287,292],"progress":[290],"dramatically":[293],"influence":[294]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2035274147","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":27},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
